CEBPB, CCAAT enhancer binding protein beta, 1051

N. diseases: 182; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.390 Biomarker disease BEFREE In this report, we activate CEPBA with saRNAs and suppress CEBPB with siRNAs in cells that represent three different degrees of HCC. 30643190 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.390 Biomarker disease BEFREE Liver-enriched activator protein 1 as an isoform of CCAAT/enhancer-binding protein beta suppresses stem cell features of hepatocellular carcinoma. 29731667 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.390 GeneticVariation disease BEFREE Our results indicated that rs12309362 (G > A), rs9970827 (A > G) in DHSs, and elevated expression of CEBPB were associated with a decreased risk of HCC. 28321907 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.390 Biomarker disease BEFREE Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas. 25965830 2015
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.390 Biomarker disease BEFREE In this study, we sought to determine the molecular mechanism of the tumor suppression activity of a short RNA from 3'UTR of C/EBPβ mRΝΑ (C/EBPβ 3'UTR RNA) in human hepatocarcinoma cells SMMC-7721. 21283634 2011
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.390 Biomarker disease BEFREE In this study, we used the opposing transcriptional effects driven by LAP and LIP to determine the genuine C/EBPbeta molecular signature in the Hep3B human hepatoma cell line. 21145827 2011
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.390 Biomarker disease CTD_human Dietary alpha-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma cells. 14563831 2004
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.390 Biomarker disease LHGDN Transfection of cDNA in 3'untranslated region of human nuclear factor for interleukin-6 (NF-IL6 3'UTR) induced tumor suppression in a human hepatoma cell line. cDNA array analysis was used to reveal changes in gene expression profile leading to tumor suppression The results indicate that this suppression was not due to activation of dsRNA-dependent protein kinase, nor to inactivation of oncogenes; rather, all the changes in expression of known genes, induced by NF-IL6 3'UTR cDNA may be ascribed to the suppression of cellular malignancy. 14728809 2003
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.390 Biomarker disease BEFREE Previous studies have shown that in human T-cells (Jurkat) and hepatoma cells (HepG2), exogenous NF-IL6 can activate HIV-1 gene expression even in the absence of its consensus binding elements in the viral long terminal repeat (LTR). 8844998 1996
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.390 Biomarker disease BEFREE Among these, IL-6DBP/NF-IL6 plays a key role in IL-6 signal transduction because its trans-activation potential is induced by IL-6 in the human hepatoma cell line Hep3B. 7680115 1993